By InvitationNot Applicable

Virtual Reality in Patients With Pulmonary Hypertension: A Randomized Controlled Trial

Turkey (Türkiye)32 participantsStarted 2026-01-31

Plain-language summary

The goal of this research is to investigate the effectiveness of exercise administered via immersive virtual reality in patients with pulmonary hypertension, thereby contributing to the existing literature on this subject. The main question is whether exercises delivered via immersive virtual reality are effective to improve physical performance, functional capacity, dyspnea, muscle strength, fatigue, quality of life, depression and anxiety.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of Idiopathic Pulmonary Arterial Hypertension, * Stable pharmacological treatment for the past 3 months, * Hemodynamic and clinical stability for at least the past three months, * Age of 18-65, * Voluntary participation in the study and signing the informed consent form, * Being classified in the World Health Organization-Functional Classification I, II or III. Exclusion Criteria: * The presence of an orthopedic or neurological problem that will affect functional tests and muscle strength measurement, * Acute decompensated heart failure, * Unstable angina pectoris, * Uncontrolled hypertension, * The presence of problems that hinder communication, * Dizziness, vertigo, * Severe visual impairment,

What they're measuring

Muscle Strength

Timeframe: at the beginning of the study and at the end of 8 week,

Hand Grip Strength

Timeframe: at the beginning of the study and at the end of 8 weeks

Functional capacity of lower extremity

Timeframe: at the beginning of the study and at the end of 8 weeks

Functional capacity of upper extremity

Timeframe: at the beginning of the study and at the end of 8 weeks

Physical performance

Timeframe: at the beginning of the study and at the end of 8 weeks

Trial details

NCT IDNCT07558460

SponsorIstanbul University - Cerrahpasa

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-01

View on ClinicalTrials.gov More Idiopathic Pulmonary Arterial Hypertension trials

Plain-language summary

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Muscle Strength

Timeframe: at the beginning of the study and at the end of 8 week,

Hand Grip Strength

Timeframe: at the beginning of the study and at the end of 8 weeks

Functional capacity of lower extremity

Timeframe: at the beginning of the study and at the end of 8 weeks

Functional capacity of upper extremity

Timeframe: at the beginning of the study and at the end of 8 weeks

Physical performance

Timeframe: at the beginning of the study and at the end of 8 weeks